Enhanced Anticancer Efficacy of Noscapine-Loaded Lipid Nanocapsules: In-vitro and In-vivo Evaluation. | ||||
| Egyptian Journal of Chemistry | ||||
| Articles in Press, Accepted Manuscript, Available Online from 30 January 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2024.259976.9129 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Nadeen Diaa Abdel-Wahab   1; Mohamed Fawzi Kabil2; Ibrahim M. El-sherbiny2; Mohamed F. Salama1; Gehad El-Sayed1; El-Said El-Sherbini1
| ||||
| 1Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Mansoura University, Egypt | ||||
| 2Nanomedicine Research Labs, Center for Materials Science, Zewail City of Science and Technology, 6th of October City, Giza, Egypt | ||||
| Abstract | ||||
| Noscapine (NOS), an alkaloid with several interesting biological applications, has demonstrated antitumor action and cough suppressant potential. However, the strong hydrophobic nature of NOS makes it poorly water-soluble. Therefore, it was necessary to figure out how to make NOS more soluble. In this study, we investigated the anticancer effect of free NOS as compared to that of NOS-loaded lipid nanocapsules (NOS-LNCs) on the 4T1 cell line, and in an orthotopic breast cancer (BC) mouse model. Spherical-shaped NOS-LNCs were prepared with a particle size (PS) of 213.4 ± 1.41 nm and a zeta potential (ZP) of -13.6 ± 1.17. The IC50 of free NOS, NOS-LNCs, and plain LNCs was measured on the 4T1 cell line by MTT assay, and the results revealed that the IC50 was 66.107 µg/ml, 13.209 µg/ml, and 121.132 µg/ml, respectively. On the other hand, NOS-LNCs demonstrated stronger anticancer effects in-vivo along with strong antiproliferative and antioxidant properties. Also, the immunohistochemistry analysis of BAX and BCL-2 in the tumor tissue confirmed the apoptotic activity of the NOS-LNCs, as it increased the expression of BAX and downregulated BCL-2. In conclusion, the current investigation showed that the developed NOS nanoform has a great deal of potential as a therapeutic agent for the treatment of BC. | ||||
| Keywords | ||||
| Noscapine; Breast cancer; Anticancer effect; Lipid nanocapsules | ||||
|
Statistics Article View: 95 |
||||
